Receptor-Mediated Bioassay Reflects Dynamic Change of Glucose-Dependent Insulinotropic Polypeptide by Dipeptidyl Peptidase 4 Inhibitor Treatment in Subjects With Type 2 Diabetes

Objective: We recently observed a greater increase in plasma levels of bioactive glucose-dependent insulinotropic polypeptide (GIP) than glucagon-like peptide 1 (GLP-1) using the receptor-mediated bioassays in the subjects with normal glycemic tolerance (NGT) treated with dipeptidyl peptidase 4 (DPP...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanagimachi, Tsuyoshi, Fujita, Yukihiro, Takeda, Yasutaka, Honjo, Jun, Yokoyama, Hiroki, Haneda, Masakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193081/
https://www.ncbi.nlm.nih.gov/pubmed/32390941
http://dx.doi.org/10.3389/fendo.2020.00214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193081/
https://www.ncbi.nlm.nih.gov/pubmed/32390941
http://dx.doi.org/10.3389/fendo.2020.00214

Ejemplares similares